- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | - | - |
| R2 | - | - |
| R3 | - | - |
| PP | - | - |
| S1 | - | - |
| S2 | - | - |
| S3 | - | - |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | -46.38 | - | -12.91 | - |
| ROE | - | 75.76 | - | 51.39 | - |
| EPS | -1.96 | -5.56 | -2.04 | -4 | -1.05 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Parmax Pharma Ltd
Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalid...
ISIN :INE240T01014
Registered Office
Plot No 20 Survey No 52,Tal Kotda Sangani Hadamtala
Contact number
+ 91-2827-270534/535
Registrars
Purva Sharegistry (I) Pvt Ltd
9 ShivShakti Indl Es J R Boricha Marg Lower Parel Mumbai - 400 011
9 ShivShakti Indl Es J R Boricha Marg Lower Parel Mumbai - 400 011
Contact number
+ 022- 23016761 / 2301
Management
- (Chairman)
Open IPO’s
FAQs
The share price of Parmax Pharma Ltd on the BSE is - as on -